AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 170 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $679,000 | -26.8% | 44,846 | -63.8% | 0.00% | -20.0% |
| Q2 2022 | $928,000 | -56.5% | 123,766 | -47.2% | 0.01% | -58.3% |
| Q1 2022 | $2,135,000 | -9.7% | 234,625 | -30.3% | 0.01% | -7.7% |
| Q4 2021 | $2,365,000 | +156.8% | 336,833 | +316.7% | 0.01% | +116.7% |
| Q3 2021 | $921,000 | -60.2% | 80,828 | -44.1% | 0.01% | -62.5% |
| Q2 2021 | $2,313,000 | -8.7% | 144,472 | +1.9% | 0.02% | -11.1% |
| Q1 2021 | $2,533,000 | +21.0% | 141,732 | -8.5% | 0.02% | 0.0% |
| Q4 2020 | $2,093,000 | -13.3% | 154,942 | -24.5% | 0.02% | -10.0% |
| Q3 2020 | $2,415,000 | +62.2% | 205,170 | +103.4% | 0.02% | +17.6% |
| Q2 2020 | $1,489,000 | +254.5% | 100,888 | +361.3% | 0.02% | +142.9% |
| Q3 2019 | $420,000 | +11.4% | 21,870 | +71.4% | 0.01% | -30.0% |
| Q2 2019 | $377,000 | -90.2% | 12,760 | -82.5% | 0.01% | -89.5% |
| Q2 2017 | $3,833,000 | +1385.7% | 72,947 | +968.5% | 0.10% | +1483.3% |
| Q4 2016 | $258,000 | -84.1% | 6,827 | -84.1% | 0.01% | -82.9% |
| Q3 2016 | $1,623,000 | – | 43,007 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|